185 related articles for article (PubMed ID: 37387444)
1. DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells.
Tan S; Zhao J; Wang P
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387444
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma.
Ding Y; Liu H; Zhang C; Bao Z; Yu S
Aging (Albany NY); 2022 Mar; 14(5):2320-2334. PubMed ID: 35256538
[TBL] [Abstract][Full Text] [Related]
3. Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling.
Alafate W; Xu D; Wu W; Xiang J; Ma X; Xie W; Bai X; Wang M; Wang J
J Exp Clin Cancer Res; 2020 Nov; 39(1):239. PubMed ID: 33176854
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.
Oueslati A; Schneider BL; Aebischer P; Lashuel HA
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3945-54. PubMed ID: 23983262
[TBL] [Abstract][Full Text] [Related]
5. DYRK1A activates NFATC1 to increase glioblastoma migration.
Liu H; Sun Q; Chen S; Chen L; Jia W; Zhao J; Sun X
Cancer Med; 2021 Sep; 10(18):6416-6427. PubMed ID: 34309232
[TBL] [Abstract][Full Text] [Related]
6. Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway.
Guo X; Zhang D; Zhang X; Jiang J; Xue P; Wu C; Zhang J; Jin G; Huang Z; Yang J; Zhu X; Liu W; Xu G; Cui Z; Bao G
Tissue Cell; 2018 Dec; 55():63-70. PubMed ID: 30503061
[TBL] [Abstract][Full Text] [Related]
7. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
8. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
Song WJ; Song EA; Jung MS; Choi SH; Baik HH; Jin BK; Kim JH; Chung SH
J Biol Chem; 2015 Jan; 290(4):2321-33. PubMed ID: 25477508
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies.
Weston LJ; Stackhouse TL; Spinelli KJ; Boutros SW; Rose EP; Osterberg VR; Luk KC; Raber J; Weissman TA; Unni VK
J Biol Chem; 2021; 296():100273. PubMed ID: 33428941
[TBL] [Abstract][Full Text] [Related]
11. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
[TBL] [Abstract][Full Text] [Related]
12. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
13. Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme.
Xia X; Cao F; Yuan X; Zhang Q; Chen W; Yu Y; Xiao H; Han C; Yao S
PeerJ; 2019; 7():e7974. PubMed ID: 31763067
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.
Pezuk JA; Brassesco MS; Morales AG; de Oliveira JC; de Paula Queiroz RG; Machado HR; Carlotti CG; Neder L; Scrideli CA; Tone LG
Cancer Gene Ther; 2013 Sep; 20(9):499-506. PubMed ID: 23887645
[TBL] [Abstract][Full Text] [Related]
15. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
16. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
[TBL] [Abstract][Full Text] [Related]
17. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
Dahmene M; Bérard M; Oueslati A
J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
[TBL] [Abstract][Full Text] [Related]
20. Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function.
Kim K; Lee S; Kang H; Shin E; Kim HY; Youn H; Youn B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
